Page last updated: 2024-10-18

dalteparin and Glaucoma, Angle Closure

dalteparin has been researched along with Glaucoma, Angle Closure in 1 studies

Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)

Research Excerpts

ExcerptRelevanceReference
"An 84-year-old woman with unstable angina pectoris was treated with subcutaneous enoxaparine (Clexane) for several days before presenting with severe pain and decreased vision in her left eye."1.31Massive choroidal hemorrhage associated with low molecular weight heparin therapy. ( Goldstein, M; Leibovitch, I; Loewenstein, A; Neudorfer, M, 2002)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Neudorfer, M1
Leibovitch, I1
Goldstein, M1
Loewenstein, A1

Other Studies

1 other study available for dalteparin and Glaucoma, Angle Closure

ArticleYear
Massive choroidal hemorrhage associated with low molecular weight heparin therapy.
    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2002, Volume: 13, Issue:3

    Topics: Acetazolamide; Aged; Aged, 80 and over; Angina, Unstable; Anticoagulants; Choroid Hemorrhage; Drug T

2002